PMC:7311890 / 22873-23093 JSONTXT

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T168","span":{"begin":161,"end":163},"obj":"Body_part"}],"attributes":[{"id":"A168","pred":"fma_id","subj":"T168","obj":"http://purl.org/sig/ont/fma/fma66592"}],"text":"Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C)."}

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T114","span":{"begin":81,"end":89},"obj":"Disease"}],"attributes":[{"id":"A114","pred":"mondo_id","subj":"T114","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"}],"text":"Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C)."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T217","span":{"begin":157,"end":163},"obj":"http://purl.obolibrary.org/obo/CLO_0053413"}],"text":"Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C)."}

{"project":"LitCovid-PubTator","denotations":[{"id":"647","span":{"begin":157,"end":163},"obj":"Gene"},{"id":"690","span":{"begin":73,"end":77},"obj":"Disease"},{"id":"691","span":{"begin":81,"end":89},"obj":"Disease"}],"attributes":[{"id":"A647","pred":"tao:has_database_id","subj":"647","obj":"Gene:335"},{"id":"A690","pred":"tao:has_database_id","subj":"690","obj":"MESH:C538394"},{"id":"A691","pred":"tao:has_database_id","subj":"691","obj":"MESH:C000657245"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C)."}

{"project":"LitCovid-sentences","denotations":[{"id":"T154","span":{"begin":0,"end":220},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C)."}

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T482","span":{"begin":11,"end":26},"obj":"CHEBI:16247;CHEBI:16247"},{"id":"T483","span":{"begin":81,"end":89},"obj":"SP_7"},{"id":"T32087","span":{"begin":3,"end":11},"obj":"SP_7"},{"id":"T24069","span":{"begin":75,"end":81},"obj":"UBERON:0001969"},{"id":"T41089","span":{"begin":82,"end":90},"obj":"CHEBI:25212;CHEBI:25212"},{"id":"T98256","span":{"begin":114,"end":122},"obj":"SP_7"}],"text":"Changes in phospholipidome therefore suggested reductions in circulating HDLs as COVID-19 progresses, which was in agreement with the observed reductions in apo-A1 (p = 0.0687) as disease severity increases (Figure S1C)."}